Nomura Holdings’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
271,110
+30,296
| +13% | +$1.31M | 0.02% | 146 |
|
|
2025
Q1 | $8.32M | Buy |
240,814
+26,686
| +12% | +$923K | 0.02% | 233 |
|
|
2024
Q4 | $5.88M | Sell |
214,128
-11,109
| -5% | -$305K | 0.01% | 343 |
|
|
2024
Q3 | $5.73M | Sell |
225,237
-2,997
| -1% | -$76.3K | 0.01% | 268 |
|
|
2024
Q2 | $5.78M | Sell |
228,234
-153,411
| -40% | -$3.89M | 0.01% | 290 |
|
|
2024
Q1 | $11.8M | Buy |
381,645
+123,650
| +48% | +$3.82M | 0.03% | 152 |
|
|
2023
Q4 | $10.4M | Buy |
257,995
+22,986
| +10% | +$928K | 0.03% | 178 |
|
|
2023
Q3 | $6.2M | Sell |
235,009
-90,744
| -28% | -$2.39M | 0.02% | 208 |
|
|
2023
Q2 | $5.6M | Buy |
325,753
+80,658
| +33% | +$1.39M | 0.02% | 178 |
|
|
2023
Q1 | $4.06M | Buy |
245,095
+129,558
| +112% | +$2.15M | 0.01% | 287 |
|
|
2022
Q4 | $878K | Sell |
115,537
-47,343
| -29% | -$360K | ﹤0.01% | 515 |
|
|
2022
Q3 | $1.62M | Buy |
162,880
+15,895
| +11% | +$158K | 0.01% | 498 |
|
|
2022
Q2 | $1.46M | Sell |
146,985
-8,826
| -6% | -$87.4K | 0.01% | 551 |
|
|
2022
Q1 | $1.69M | Sell |
155,811
-71,046
| -31% | -$772K | 0.01% | 582 |
|
|
2021
Q4 | $3.79M | Buy |
226,857
+1,878
| +0.8% | +$31.3K | 0.01% | 486 |
|
|
2021
Q3 | $10.7M | Buy |
224,979
+1,516
| +0.7% | +$72.4K | 0.03% | 207 |
|
|
2021
Q2 | $13.6M | Buy |
223,463
+249
| +0.1% | +$15.2K | 0.03% | 157 |
|
|
2021
Q1 | $13.7M | Buy |
223,214
+218,884
| +5,055% | +$13.5M | 0.03% | 151 |
|
|
2020
Q4 | $308K | Sell |
4,330
-9,368
| -68% | -$666K | ﹤0.01% | 930 |
|
|
2020
Q3 | $514K | Buy |
+13,698
| New | +$514K | ﹤0.01% | 672 |
|